etoposide has been researched along with Leukemia, Megakaryocytic in 19 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 1 (5.26) | 18.7374 |
| 1990's | 6 (31.58) | 18.2507 |
| 2000's | 8 (42.11) | 29.6817 |
| 2010's | 3 (15.79) | 24.3611 |
| 2020's | 1 (5.26) | 2.80 |
| Authors | Studies |
|---|---|
| Ishibashi, N; Kondo, T; Mitomo, H; Murakami, K; Nonomura, R; Oshima, Y; Sagawa, M; Sasaki, T; Sugawara, T; Tabata, T | 1 |
| Cha, YJ; Kim, HR; Kim, JW; Park, EK; Yu, N | 1 |
| Balci, TB; Berman, JN; Buck, SA; Dellaire, G; Dombkowski, AA; Edwards, H; Ge, Y; Matherly, LH; Taub, JW; Xavier, AC; Xie, C | 1 |
| Akahane, D; Fujikawa, Y; Ichikawa, N; Kobayashi, H; Sato, K; Shimizu, I; Sumi, M; Tokushige, J; Ueki, T; Ueno, M | 1 |
| Bacigalupo, A; Ferrua, MT; Gallamini, A; Ghirardo, D; Lo Nigro, C; Mattei, D; Mordini, N; Osenda, M; Viscoli, C | 1 |
| Fouillard, L; Frassoni, F; Gorin, NC; Labopin, M; Meloni, G; Polge, E | 1 |
| Creutzig, U; Diekamp, S; Dworzak, M; Fleischhack, G; Harbott, J; Langebrake, C; Ludwig, WD; Reinhardt, D; Ritter, J; Schrauder, A; Stary, J; Zimmermann, M | 1 |
| Creutzig, U; Diekamp, S; Dworzak, M; Reinhardt, D; Stary, J; Zimmermann, M | 1 |
| Ito, E; Kanezaki, R; Narayanan, R; Toki, T; Xu, G | 1 |
| Hamamoto, K; Hanada, R; Horibe, K; Imaizumi, M; Kigasawa, H; Kobayashi, R; Kojima, S; Kudo, K; Morimoto, A; Nakayama, H; Tabuchi, K; Tawa, A; Tsuchida, M; Tsukimoto, I; Yabe, H | 1 |
| Bertoglio, J; Bréard, J; Issaad, C; Léglise, MC; Pallardy, M; Roger, R; Turhan, AG | 1 |
| Hidaka, E; Ito, S; Koike, K; Koike, T; Komiyama, A; Kurokawa, Y; Matsuura, H; Miki, J; Nakazawa, T; Sakashita, K; Sawai, N | 1 |
| Akiyama, Y; Eguchi, M; Hayashi, Y; Hosoi, G; Ishii, E; Kato, K; Koike, K; Kojima, S; Nishimura, S; Ohara, A; Okamura, J; Okimoto, Y; Sako, M; Sato, T; Tsukimoto, I; Ueda, K; Yazaki, M; Yoshikawa, T | 1 |
| Behm, FG; Pritchard, M; Pui, CH; Raimondi, SC; Razzouk, BI; Ribeiro, RC; Rubnitz, JE; Sandlund, JT; Srivastava, DK; Tong, X | 1 |
| Granada, I; Las Heras, G; Millá, F; Ribera, JM | 1 |
| Farhi, DC; Rosenthal, NS | 1 |
| Donhuijsen-Ant, R; Leder, LD; Löffler, H; Schadeck-Gressel, C; Schmidt, U; Westerhausen, M | 1 |
| Kühn, B; Löffler, H; Polchau, H; Rister, M; Suttorp, M | 1 |
| Brecher, ML; Freeman, AI; Green, DM; Sandberg, AA; Simon, JH; Tebbi, CK | 1 |
2 review(s) available for etoposide and Leukemia, Megakaryocytic
| Article | Year |
|---|---|
Acute megakaryoblastic leukemia: a case report.
Topics: Acid Phosphatase; Aged; Amsacrine; Antineoplastic Combined Chemotherapy Protocols; Bone Marrow; Cytarabine; Etoposide; Humans; Leukemia, Megakaryoblastic, Acute; Male; Neoplasm Proteins; Neoplastic Stem Cells; Primary Myelofibrosis | 1990 |
Acute megakaryoblastic leukemia associated with mosaic Down's syndrome.
Topics: Amsacrine; Antineoplastic Combined Chemotherapy Protocols; Chromosomes, Human, Pair 17; Clone Cells; Cyclophosphamide; Cytarabine; Down Syndrome; Doxorubicin; Etoposide; Female; Humans; Hydrocortisone; Infant; Leukemia, Megakaryoblastic, Acute; Methotrexate; Mosaicism; Prednisone; Thioguanine; Trisomy | 1987 |
3 trial(s) available for etoposide and Leukemia, Megakaryocytic
| Article | Year |
|---|---|
AML patients with Down syndrome have a high cure rate with AML-BFM therapy with reduced dose intensity.
Topics: Adolescent; Age Factors; Antineoplastic Combined Chemotherapy Protocols; Child; Child, Preschool; Cytarabine; Disease-Free Survival; Down Syndrome; Etoposide; Female; Humans; Idarubicin; Infant; Leukemia, Megakaryoblastic, Acute; Leukemia, Myeloid, Acute; Male; Survival Rate; Treatment Outcome | 2005 |
Prospective study of a pirarubicin, intermediate-dose cytarabine, and etoposide regimen in children with Down syndrome and acute myeloid leukemia: the Japanese Childhood AML Cooperative Study Group.
Topics: Antineoplastic Combined Chemotherapy Protocols; Child; Child, Preschool; Cytarabine; Disease-Free Survival; Down Syndrome; Doxorubicin; Etoposide; Female; Humans; Infant; Leukemia, Megakaryoblastic, Acute; Male; Prospective Studies; Treatment Outcome | 2007 |
An effective chemotherapeutic regimen for acute myeloid leukemia and myelodysplastic syndrome in children with Down's syndrome.
Topics: Antineoplastic Combined Chemotherapy Protocols; Child, Preschool; Cytarabine; Daunorubicin; Disease-Free Survival; Down Syndrome; Etoposide; Female; Humans; Infant; Leukemia, Megakaryoblastic, Acute; Leukemia, Myeloid, Acute; Male; Myelodysplastic Syndromes; Probability; Remission Induction; Survival Rate; Time Factors; Treatment Outcome | 2000 |
14 other study(ies) available for etoposide and Leukemia, Megakaryocytic
| Article | Year |
|---|---|
[Acute Megakaryoblastic Leukemia Developed after the Surgical Treatment of Mediastinal Malignant Germ Cell Tumor].
Topics: Adult; Antineoplastic Combined Chemotherapy Protocols; Child; Etoposide; Humans; Leukemia, Megakaryoblastic, Acute; Male; Mediastinal Neoplasms; Neoplasms, Germ Cell and Embryonal | 2020 |
Development of acute megakaryoblastic leukemia with isochromosome (12p) after a primary mediastinal germ cell tumor in Korea.
Topics: Adult; Antineoplastic Combined Chemotherapy Protocols; Bleomycin; Bone Marrow; Chromosomes, Human, Pair 12; Cisplatin; Etoposide; Humans; Isochromosomes; Karyotyping; Leukemia, Megakaryoblastic, Acute; Male; Mediastinal Neoplasms; Neoplasms, Germ Cell and Embryonal; Neoplasms, Second Primary; Republic of Korea; Shock, Septic | 2011 |
A unique role of GATA1s in Down syndrome acute megakaryocytic leukemia biology and therapy.
Topics: Cell Differentiation; Cell Line, Tumor; Cell Proliferation; Cell Survival; Cytarabine; Daunorubicin; Down Syndrome; Down-Regulation; Etoposide; GATA1 Transcription Factor; Gene Expression Regulation, Neoplastic; Gene Knockdown Techniques; Humans; Interleukin-1alpha; Lentivirus; Leukemia, Megakaryoblastic, Acute; Megakaryocytes; Proto-Oncogene Proteins c-bcl-2; RNA, Small Interfering | 2011 |
[Successful treatment with low-dose etoposide for hemophagocytic syndrome following reduced-intensity conditioning for cord blood transplantation in a patient with acute myelgenous leukemia].
Topics: Etoposide; Fetal Blood; Humans; Leukemia, Megakaryoblastic, Acute; Lymphohistiocytosis, Hemophagocytic; Male; Middle Aged; Transplantation Conditioning; Treatment Outcome | 2012 |
Voriconazole in the management of invasive aspergillosis in two patients with acute myeloid leukemia undergoing stem cell transplantation.
Topics: Adult; Amphotericin B; Antineoplastic Combined Chemotherapy Protocols; Aspergillosis; Bone Marrow Transplantation; Combined Modality Therapy; Cytarabine; Daunorubicin; Deoxycholic Acid; Drug Combinations; Drug Resistance, Fungal; Etoposide; Fatal Outcome; Humans; Immunocompromised Host; Itraconazole; Leukemia, Megakaryoblastic, Acute; Leukemia, Myelomonocytic, Acute; Liposomes; Lung Diseases, Fungal; Male; Middle Aged; Peripheral Blood Stem Cell Transplantation; Pyrimidines; Recurrence; Remission Induction; Salvage Therapy; Transplantation Conditioning; Transplantation, Autologous; Transplantation, Homologous; Triazoles; Voriconazole | 2002 |
Comparison of BAVC to BuCy regimens in autologous stem cell transplantation for adult patients with acute myeloid leukemia.
Topics: Adolescent; Adult; Aged; Amsacrine; Antineoplastic Combined Chemotherapy Protocols; Busulfan; Carmustine; Combined Modality Therapy; Cyclophosphamide; Cytarabine; Drug Combinations; Etoposide; Female; Humans; Leukemia, Erythroblastic, Acute; Leukemia, Megakaryoblastic, Acute; Leukemia, Monocytic, Acute; Leukemia, Myeloid; Leukemia, Myeloid, Acute; Leukemia, Myelomonocytic, Acute; Leukemia, Promyelocytic, Acute; Male; Middle Aged; Retrospective Studies; Stem Cell Transplantation; Transplantation, Autologous | 2004 |
Acute megakaryoblastic leukemia in children and adolescents, excluding Down's syndrome: improved outcome with intensified induction treatment.
Topics: Adolescent; Antineoplastic Combined Chemotherapy Protocols; Child; Child, Preschool; Clinical Trials as Topic; Cytarabine; Etoposide; Female; Humans; Idarubicin; Infant; Leukemia, Megakaryoblastic, Acute; Male; Remission Induction; Retrospective Studies; Survival Analysis; Treatment Outcome | 2005 |
Cloning and characterization of the novel chimeric gene p53/FXR2 in the acute megakaryoblastic leukemia cell line CMK11-5.
Topics: Animals; Base Sequence; Cell Line, Tumor; Cell Transformation, Neoplastic; Chlorocebus aethiops; Cloning, Molecular; COS Cells; Cyclin-Dependent Kinase Inhibitor p21; Etoposide; Gene Expression Profiling; Genes, p53; Humans; Leukemia, Megakaryoblastic, Acute; Mice; Molecular Sequence Data; Mutant Chimeric Proteins; NIH 3T3 Cells; RNA-Binding Proteins; Topoisomerase II Inhibitors | 2006 |
BCR-ABL does not prevent apoptotic death induced by human natural killer or lymphokine-activated killer cells.
Topics: Apoptosis; Camptothecin; Cycloheximide; Cytotoxicity, Immunologic; Dactinomycin; DNA Damage; DNA, Neoplasm; Etoposide; Fusion Proteins, bcr-abl; Hematopoietic Stem Cells; Humans; Hydrogen Peroxide; Killer Cells, Lymphokine-Activated; Killer Cells, Natural; Leukemia, Megakaryoblastic, Acute; Leukemia, Myelogenous, Chronic, BCR-ABL Positive; Puromycin; Recombinant Fusion Proteins; Transfection; Tumor Cells, Cultured; Tumor Necrosis Factor-alpha | 1996 |
[The value of intracellular CD41 antigen detection to the diagnosis of acute megakaryoblastic leukemia].
Topics: Antineoplastic Combined Chemotherapy Protocols; Cytarabine; Etoposide; Humans; Infant; Leukemia, Megakaryoblastic, Acute; Male; Megakaryocytes; Mitoxantrone; Platelet Glycoprotein GPIIb-IIIa Complex; Remission Induction | 1999 |
Impact of treatment on the outcome of acute myeloid leukemia with inversion 16: a single institution's experience.
Topics: Acute Disease; Adolescent; Antineoplastic Agents; Bone Marrow Transplantation; Child; Child, Preschool; Chromosome Inversion; Chromosomes, Human, Pair 16; Cladribine; Combined Modality Therapy; Cytarabine; Drug Therapy, Combination; Etoposide; Female; Humans; Infant; Leukemia, Megakaryoblastic, Acute; Leukemia, Monocytic, Acute; Leukemia, Myeloid; Leukemia, Myeloid, Acute; Leukemia, Myelomonocytic, Acute; Male; Prognosis; Treatment Outcome | 2001 |
[Acute myeloblastic leukemia 5q-. Clinical and cytogenetic remission by means of intensive chemotherapy].
Topics: Amsacrine; Antineoplastic Combined Chemotherapy Protocols; Chromosome Deletion; Chromosomes, Human, Pair 5; Cytarabine; Daunorubicin; Etoposide; Humans; Leukemia, Megakaryoblastic, Acute; Male; Middle Aged; Mitoxantrone; Mosaicism; Remission Induction | 1991 |
Dysmegakaryopoiesis resembling acute megakaryoblastic leukemia in treated acute myeloid leukemia.
Topics: Acute Disease; Antigens, CD; Bone Marrow; Cytarabine; Daunorubicin; Diagnosis, Differential; Doxorubicin; Etoposide; Humans; Hyperplasia; Immunophenotyping; Leukemia, Megakaryoblastic, Acute; Leukemia, Myeloid; Megakaryocytes; Mitoxantrone; Myelodysplastic Syndromes; Prognosis; Time Factors | 1991 |
Acute megakaryoblastic leukemia (FAB-M7) in an infant presenting with orbital chloroma and meningeal involvement.
Topics: Antineoplastic Combined Chemotherapy Protocols; Bone Marrow; Combined Modality Therapy; Cyclophosphamide; Cytarabine; Daunorubicin; Doxorubicin; Etoposide; Exophthalmos; Humans; Infant; Leukemia, Megakaryoblastic, Acute; Male; Meningeal Neoplasms; Mitoxantrone; Orbital Neoplasms; Prednisone; Thioguanine; Vincristine | 1990 |